Subpart D. Subpart D—Provisional Health Effects Guidelines

• § 795.225 - Dermal pharmacokinetics of DGBE and DGBA.
• § 795.228 - Oral/dermal pharmacokinetics.
• § 795.231 - Pharmacokinetics of isopropanal.
• § 795.232 - Inhalation and dermal pharmacokinetics of commercial hexane.
• § 795.250 - Developmental neurotoxicity screen.